FDA Commissioner Calls For Sarepta Drug Study To Be Retracted
September 22, 2016 | The study explored whether the Sarepta drug for Duchenne muscular dystrophy can sufficiently produce higher levels of a protein that provides mobility. STAT
September 22, 2016 | The study explored whether the Sarepta drug for Duchenne muscular dystrophy can sufficiently produce higher levels of a protein that provides mobility. STAT
